pSivida
| Public company | |
| Traded as | NASDAQ: PSDV ASX: PVA FWB: PV3 |
| Industry | Pharmaceuticals |
| Headquarters | Watertown, Massachusetts, USA |
Number of locations | 2 |
| Products | Iluvien |
| Website |
www |
pSivida is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.
See also
- Alimera Sciences, pSvida's partner on Iluvien
External links
- Official website
- "pSivida (PSDV) Enters Two Funded Evaluation Agreements with Leading Pharma". StreetInsider.com. May 12, 2015. Retrieved May 15, 2015.
- Lindon, Hal (May 5, 2014). "UPDATE: pSivida Issues Presentation of Preclinical Data Showing Sustained Release of Avastin Using Tethadur". Benzinga. Retrieved May 15, 2015.
pSivida's Dinesh K. Nadarassan presented a poster entitled “Sustained Release of Bevacizumab (Avastin) from BioSilicon”
| ||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, May 31, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.